riociguat 0.5 MG Oral Tablet

Known as: RIOCIGUAT 0.5MG TAB, RIOCIGUAT 0.5MG TAB,UD [VA Product], RIOCIGUAT 0.5MG TAB UD 
 
National Institutes of Health

Related topics

Related topics

4 relations
Guanylate Cyclase Stimulators [MoA]Hypertensive diseaseOral Tabletriociguat

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
NT - 483 - 2018 - Riociguat - NAT-JUS - TJMG
 
Is this relevant?
2015
2015
The sGC-stimulator Riociguat for the treatment of Raynaud's phenomenon: A single-dose, double-blind, randomized, placebo-controlled cross-over study (DIGIT)
Background Raynaud’s phenomenon (RP) is a coldor stress-triggered digital ischemia caused by vasoconstriction in the digital… (More)
Is this relevant?
2013
2013
Riociguat zur Therapie der inoperablen chronisch thromboembolischen pulmonalen Hypertonie: Eine randomisierte, doppelblinde, placebokontrollierte Phase-III-Studie (CHEST-1)
 
Is this relevant?